Lindbrook Capital, LLC - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 205 filers reported holding PTC THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
Lindbrook Capital, LLC ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$19,143
+26.3%
626
+20.2%
0.00%
+100.0%
Q1 2024$15,156
+5.6%
5210.0%0.00%0.0%
Q4 2023$14,359
+2109.1%
521
+1696.6%
0.00%
Q3 2023$650
-11.2%
29
+61.1%
0.00%
Q2 2023$732
+88.7%
18
+125.0%
0.00%
Q1 2023$388
+153.6%
8
+100.0%
0.00%
Q4 2022$153
-92.4%
4
-90.0%
0.00%
Q3 2022$2,000
+100.0%
40
+110.5%
0.00%
Q2 2022$1,0000.0%19
-17.4%
0.00%
Q1 2022$1,0000.0%23
+43.8%
0.00%
Q1 2021$1,000160.00%
Other shareholders
PTC THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Asymmetry Capital Management, L.P. 110,794$3,802,00010.50%
Boxer Capital, LLC 2,155,000$73,960,0009.14%
RTW INVESTMENTS, LP 1,922,346$65,975,0006.14%
GREAT POINT PARTNERS LLC 1,225,000$42,042,0005.31%
Opaleye Management Inc. 190,000$6,520,0002.43%
SCOPIA CAPITAL MANAGEMENT LP 1,626,965$55,837,0001.89%
SPHERA FUNDS MANAGEMENT LTD. 345,500$11,858,0001.34%
SECTORAL ASSET MANAGEMENT INC 233,536$8,015,0001.09%
Elk Creek Partners, LLC 377,674$12,962,0001.08%
Orbimed Advisors 1,519,700$52,156,0000.96%
View complete list of PTC THERAPEUTICS INC shareholders